| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30,367 |
26,814 |
$2.00M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
26,498 |
24,555 |
$1.82M |
| 88312 |
|
11,077 |
11,049 |
$571K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
23,456 |
20,826 |
$490K |
| 88313 |
|
7,854 |
7,841 |
$353K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,082 |
2,006 |
$177K |
| 88121 |
|
968 |
965 |
$163K |
| 88342 |
|
4,937 |
4,922 |
$131K |
| 88112 |
|
2,028 |
1,975 |
$42K |
| 88341 |
|
301 |
300 |
$22K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,679 |
3,355 |
$10K |
| 86328 |
|
39 |
38 |
$1K |
| 99080 |
|
94 |
91 |
$0.00 |
| 99000 |
|
63 |
63 |
$0.00 |